[ad_1]
Russia said its Sputnik V vaccine against COVID-19, developed by the Gamaleya Research Center in Moscow, is 95% effective.
“Sputnik V is the most accessible vaccine of those that are over 90% effective in Phase 3 clinical trials,” said Kirill Dmitriev, director of the Russian Sovereign Fund.
These are preliminary results obtained with the volunteers. However, No.or explained how many cases were used in the calculations.
Russia, ready to fight to lead the vaccine race, announced, before conducting large-scale clinical trials, that Sputnik V was highly effective, which raised the doubts of the international scientific community.
It is a “viral vector” -based vaccine, which uses two injections of two adenoviruses, a very common type of cold-causing virus, modified with part of the virus responsible for COVID-19.
The name of the vaccine refers to the first Russian satellite that won the race against the United States to conquer space.
Who sees the light at the end of the tunnel
The World Health Organization has expressed concern about the possible stampede caused by obtaining the vaccine, which it could trample on the poorest countries, although he sees the development of new vaccines as good news for ending the pandemic.
“With the latest positive news from vaccine testing, the light at the end of this long, dark tunnel is getting brighter,” said Dr. Tedros Adhanom Ghebreyesus, WHO Director-General.
The Oxford vaccine would be the cheapest
The prices of vaccines on the market would vary by several thousand pesos:
- Oxford’s – AstraZeneca, the cheapest, would cost 12,932 pesos.
- Pfizer’s – BioNTech would cost 64,663 pesos.
- Moderna’s would cost seven times more than Oxford’s: 90,529 pesos.
- Sputnik V would cost less than 36,000 pesos.
Meanwhile, Austria plans to start its COVID-19 vaccination campaign in January, acquiring over 16 million doses. The elderly, at-risk groups and health care workers will be first in line.
[ad_2]
Source link
